Clinical trial
Pulse Dexamethasone Over 48 Weeks for Podocyte Disease
NCT00065611 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulse Dexamethasone Over 48 Weeks for Podocyte Disease
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- August 31, 2010
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focal lipoid glomerulosclerosis, nephrosis